Deadline for public comment submissions is May 26
The National Institutes of Health (NIH) has released draft guidance for federally funded stem cell research in its effort to implement President Obama's executive order issued March 9.
The draft guidelines would allow federal funds to support research conducted on stem cell lines derived from excess fertility clinic embryos, but they expressly prohibit funding for research projects using lines derived for the purpose of research through processes such as somatic cell nuclear transfer (SCNT), in vitro fertilization (IVF) or parthenogenesis.
Also described in detail are the conditions, informed consent procedures, and other criteria that must be met during the derivation of embryonic stem cells for the cells to be eligible for research projects that are federally funded.
The draft guidelines do not explicitly ensure that current lines that are already being used in research will be eligible for federal funding.
The NIH is accepting public comment on the draft guidelines until May 26. Final guidelines are expected to be issued by July 7.
Read More from the May Edition of the AACR Cancer Policy Monitor: